QR koda

Assessing the intracranial metabolic score as a novel prognostic tool in primary CNS lymphoma with end of induction-chemotherapy 18F-FDG PET/CT and PET/MR

Abstract Background The metabolic response of primary central nervous system lymphoma (PCNSL) patients has yet to be evaluated. This study aimed to assess the prognostic value of a novel scoring scale, the intracranial metabolic score (IMS), in PCNSL patients receiving end-of-therapy 18F-FDG PET/CT...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Principais autores: Yiwen Mo, Yongjiang Li, Yuqian Huang, Mingshi Chen, Chao Zhou, Xinling Li, Yuan Wei, Ruping Li, Wei Fan, Xu Zhang
Format: Artigo
Jezik:Inglês
Izdano: BMC 2024-11-01
Serija:Cancer Imaging
Teme:
Online dostop:https://doi.org/10.1186/s40644-024-00798-1
Oznake: Označite
Brez oznak, prvi označite!